NCT04335656View on ClinicalTrials.gov

Reducing Innate Inflammation in New Onset Type 1 Diabetes

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

May 31, 2026

Study Completion Date

December 31, 2026

Conditions
Type 1 Diabetestype1diabetesType 1 Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Lactiplantibacillus plantarum

Probiotic capsule in powder form, which can be swallowed or opened and contents sprinkled on cold foods or beverages

OTHER

Placebo

Placebo capsule in powder form, which can be swallowed or opened and contents sprinkled on cold foods or beverages

Trial Locations (1)

53226

Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER